Literature DB >> 8692948

17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus.

P C Galipeau1, D S Cowan, C A Sanchez, M T Barrett, M J Emond, D S Levine, P S Rabinovitch, B J Reid.   

Abstract

Increased 4N (G2/tetraploid) cell populations have been postulated to be genetically unstable intermediates in the progression to many cancers, but the mechanism by which they develop and their relationship to instability have been difficult to investigate in humans in vivo. Barrett's esophagus is an excellent model system in which to investigate the order in which genetic and cell cycle abnormalities develop relative to each other during human neoplastic progression. Neoplastic progression in Barrett's esophagus is characterized by inactivation of the p53 gene, the development of increased 4N (G2/tetraploid) cell fractions, and the appearance of aneuploid cell populations. We investigated the hypothesis that patients whose biopsies have increased 4N (G2/tetraploid) cell fractions are predisposed to progression to aneuploidy and determined the relationship between inactivation of p53 and the development of 4N abnormalities in Barrett's epithelium. Our results indicate that increased 4N (G2/tetraploid) populations predict progression to aneuploidy and that the development of 4N abnormalities is interdependent with inactivation of the p53 gene in Barrett's esophagus in vivo.

Entities:  

Mesh:

Year:  1996        PMID: 8692948      PMCID: PMC38939          DOI: 10.1073/pnas.93.14.7081

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Sequential gene function in the initiation of Saccharomyces cerevisiae DNA synthesis.

Authors:  L M Hereford; L H Hartwell
Journal:  J Mol Biol       Date:  1974-04-15       Impact factor: 5.469

2.  Endoscopic surveillance for patients with Barrett esophagus: does the cancer risk justify the practice?

Authors:  S J Spechler
Journal:  Ann Intern Med       Date:  1987-06       Impact factor: 25.391

3.  Progression to cancer in Barrett's esophagus is associated with genomic instability.

Authors:  P S Rabinovitch; B J Reid; R C Haggitt; T H Norwood; C E Rubin
Journal:  Lab Invest       Date:  1989-01       Impact factor: 5.662

4.  Genotypic analysis of multiple loci in somatic cells by whole genome amplification.

Authors:  M T Barrett; B J Reid; G Joslyn
Journal:  Nucleic Acids Res       Date:  1995-09-11       Impact factor: 16.971

5.  Cellular DNA content as a marker of neoplasia in man.

Authors:  B Barlogie; B Drewinko; J Schumann; W Göhde; G Dosik; J Latreille; D A Johnston; E J Freireich
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

6.  The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus.

Authors:  A J Cameron; B J Ott; W S Payne
Journal:  N Engl J Med       Date:  1985-10-03       Impact factor: 91.245

7.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

8.  Barrett's esophagus: development of dysplasia and adenocarcinoma.

Authors:  W Hameeteman; G N Tytgat; H J Houthoff; J G van den Tweel
Journal:  Gastroenterology       Date:  1989-05       Impact factor: 22.682

9.  Model for the genetic evolution of human solid tumors.

Authors:  S E Shackney; C A Smith; B W Miller; D R Burholt; K Murtha; H R Giles; D M Ketterer; A A Pollice
Journal:  Cancer Res       Date:  1989-06-15       Impact factor: 12.701

10.  The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae.

Authors:  T A Weinert; L H Hartwell
Journal:  Science       Date:  1988-07-15       Impact factor: 47.728

View more
  121 in total

Review 1.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 2.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

Authors:  J A Jankowski; N A Wright; S J Meltzer; G Triadafilopoulos; K Geboes; A G Casson; D Kerr; L S Young
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

3.  Single nucleotide polymorphism array analysis of flow-sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer.

Authors:  Elizabeth L Schubert; Li Hsu; Laura A Cousens; Jeri Glogovac; Steve Self; Brian J Reid; Peter S Rabinovitch; Peggy L Porter
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

4.  Loss of heterozygosity analysis using whole genome amplification, cell sorting, and fluorescence-based PCR.

Authors:  T G Paulson; P C Galipeau; B J Reid
Journal:  Genome Res       Date:  1999-05       Impact factor: 9.043

5.  Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1.

Authors:  P R Andreassen; O D Lohez; F B Lacroix; R L Margolis
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 6.  Surveillance in Barrett's oesophagus: a personal view.

Authors:  K K Basu; J S de Caestecker
Journal:  Postgrad Med J       Date:  2002-05       Impact factor: 2.401

Review 7.  Early events during neoplastic progression in Barrett's esophagus.

Authors:  Brian J Reid
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

8.  Persistent telomere damage induces bypass of mitosis and tetraploidy.

Authors:  Teresa Davoli; Eros Lazzerini Denchi; Titia de Lange
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

9.  FLJ25439, a novel cytokinesis-associated protein, induces tetraploidization and maintains chromosomal stability via enhancing expression of endoplasmic reticulum stress chaperones.

Authors:  Tai-Long Pan; Shu-Yuan Hsu; Pei-Wen Wang; Ya-Ting Cheng; Yu-Chen Chang; Sudipta Saha; Jiwei Hu; Pin Ouyang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

10.  Integrins promote cytokinesis through the RSK signaling axis.

Authors:  Shomita S Mathew; Bethsaida Nieves; Sharon Sequeira; Savitha Sambandamoorthy; Kevin Pumiglia; Melinda Larsen; Susan E Laflamme
Journal:  J Cell Sci       Date:  2013-11-27       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.